Literature DB >> 24065758

eComment. Levosimendan in adult patients undergoing cardiac surgery.

Jamil Hajj-Chahine1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24065758      PMCID： PMC3781814          DOI： 10.1093/icvts/ivt328

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN： 1569-9285


× No keyword cloud information.
  5 in total

Review 1.  Levosimendan in cardiac surgery: current best available evidence.

Authors:  Shahzad G Raja; Benson S Rayen
Journal:  Ann Thorac Surg       Date:  2006-04       Impact factor: 4.330

Review 2.  Is levosimendan effective in paediatric heart failure and post-cardiac surgeries?

Authors:  Ullas Angadi; Claire Westrope; Mohammed F Chowdhry
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-07-06

Review 3.  Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies.

Authors:  Giovanni Landoni; Giuseppe Biondi-Zoccai; Massimiliano Greco; Teresa Greco; Elena Bignami; Andrea Morelli; Fabio Guarracino; Alberto Zangrillo
Journal:  Crit Care Med       Date:  2012-02       Impact factor: 7.598

4.  Efficacy and safety of perioperative infusion of levosimendan in patients with compromised cardiac function undergoing open-heart surgery: importance of early use.

Authors:  Androniki Tasouli; Kirillos Papadopoulos; Theophanie Antoniou; Ioannis Kriaras; Georges Stavridis; Dimitrios Degiannis; Stephanos Geroulanos
Journal:  Eur J Cardiothorac Surg       Date:  2007-08-15       Impact factor: 4.191

5.  Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function.

Authors:  Heidi I Eriksson; Jouko R Jalonen; Leo O Heikkinen; Matti Kivikko; Mika Laine; Kari A Leino; Anne H Kuitunen; Kari T Kuttila; Tarja K Peräkylä; Toni Sarapohja; Raili T Suojaranta-Ylinen; Mika Valtonen; Markku T Salmenperä
Journal:  Ann Thorac Surg       Date:  2009-02       Impact factor: 4.330
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.